The production of potentially pathogenic anti-DNA autoantibodies in SLE is driven by special, autoimmune T helper (Th) cells. Herein, we sequenced the T cell receptor (TCR) a and P chain genes expressed by 42 autoimmune Th lines from lupus patients that were mostly CD4+ and represented the strongest inducers of such autoantibodies. These autoinmune TCRs displayed a recurrent motif of highly charged residues in their CDR3 loops that were contributed by Nnucleotide additions and also positioned there by the recombination process. Furthermore, Th lines from four of the five patients showed a marked increase in the usage of the Va8 gene family. Several independent Th lines expressed identical TCR a and/or ,B chain sequences indicating again antigenic selection. 10 of these Th lines could be tested further for antigenic specificity. 4 of the 10 pathogenic anti-DNA autoantibody-inducing Th lines responded to the nonhistone chromosomal protein HMG and two responded to nucleosomal histone proteins; all presented by HLA-DR molecules. Another Th line responded to purified DNA more than nucleosomes. Thus, these autoimmune Th cells of lupus patients respond to charged epitopes in various DNA-binding nucleoproteins that are probably processed and presented by the anti-DNA B cells they selectively help. (J. Clin. Invest. 1995. 95:531-541.)
Introduction
Lupus nephritis in humans, as in mice, is associated with the spontaneous production of pathogenic anti-DNA autoantibodies that are IgG in class and cationic in charge (1) (2) (3) (4) (5) (6) (7) . B cells producing these autoantibodies in active lupus appear to be selected by some autoantigen(s) since they show evidence of clonal expansion (1, 6) as well as somatic mutations that generate cationic residues in their autoantibody V regions (for reviews see reference [8] [9] [10] . The production of these potentially patho-that are detectable in patients with active lupus nephritis, but not in normal subjects or lupus patients in remission (1) . Although the antigenic specificities of these T cells were unknown, we isolated these Th cell lines in vitro by selecting for their special functional properties (1, 11) . Among 396 T cell lines that were established by limiting dilution cultures of the spontaneously activated T cells from five patients with lupus nephritis, only 59 (ns 15%) had the ability to selectively augment the production of potentially pathogenic anti-DNA autoantibodies when cultured with autologous B cells (11) . Therefore, these autoantibody-inducing Th cells of lupus are a special group of autoimmune T cells that are distinct from conventional "autoreactive" T cells. Although certain double negative (CD4-/CD8-) Th cells, as well as certain CD8+ Th cells, are important components of this autoantibody-inducing T cell population, their contribution is probably secondary in SLE (1, (11) (12) (13) . The CD4+ Th cells might be the prime movers in the pathogenic autoimmune response, since they are most prevalent among the autoimmune Th clones (49 out of 59) and they also are the strongest helpers, increasing IgG anti-DNA autoantibody production up to 250-fold when cocultured with autologous B cells (1 1) . To determine the basic mechanism of the pathogenic autoimmune response in human SLE, the structure and antigenic specificity of the receptors expressed by these spontaneously arising autoimmune Th cells have to be analyzed first. Herein, we determined the sequences of the a and /3 chain TCR genes JCA  0102  0301  02  09  0101  0101  0101  0602  0201  MCM  0101  0501  0102  11  02  0501  0301  DS-2  0101  0501  0101  0301  0101  0501  0201  SE-2  0501  0301  0101  0201  HS-2  0102  0301  02  04  0101  0101  0602  0302 nested C region primers. For stage I PCR (20 cycles), 20 td of cDNA was amplified using 40 pmol each of 5' V13 or Va consensus primer (sense) with EcoRI site and 3' C/3 or Ca external primer (antisense) for TCR P and a chains, respectively, as described (16, 17) . The stage II amplification (25 cycles) was performed with 1-2 ul (for TCR /3 chain) or 2-5 bA1 (for TCR a chain) of stage I reaction product using 100 pmol each of 5' VP3 or Va consensus primer and 3' Co3 or Ca internal primer (antisense) with EcoRI site, as described (16, 17) . The amplified cDNA product of expected size was gel-purified, digested with EcoRI, purified further and cloned into pucl9, and sequenced with Cf3 internal or Ca internal primers, as described (12, 14, 15) . From two to nine independent colonies were sequenced from each TCR cDNA amplification product. Independent verification of TCR sequences was obtained in some cases by using a linker-ligated PCR technique (15) . Only the functional TCR a chain sequences are shown in the results section. Two in-frame (functional) TCR a chain sequences were obtained in seven Th lines (see Results), whereas in the other Th lines a single functional a chain sequence with or without a second out of frame sequence (not shown) was obtained. The identities of TCR gene family sequences obtained here were established by comparing them with published sequences (18) (19) (20) (21) (22) (23) (24) (25) .
Antigens. High mobility group (HMG) chromosomal proteins containing HMG-1, 2, 14, and 17 were prepared and purified from fetal calf thymus using the 5% perchloric acid extraction method as described (26) . Protein concentration of the HMG preparation was estimated by BCA kit (Pierce, Rockford, IL). To prepare HMG/DNA complex, HMG and purified double-stranded (ds) DNA from calf thymus (Sigma Chemical Co., St. Louis, MO) were combined together at 0.1:1 or 1:1 ratios, rocked overnight at 4C before addition into the antigen-specific proliferation assays. Purified recombinant HMG-I and HMG-17 proteins were obtained from Dr. Stephen Lippard (Massachusetts Institute of Technology, Cambridge, MA) and Dr. Michael Bustin (National Institutes of Health, Bethesda, MD) (27, 28) . Mononucleosomes (Nuc) were prepared as described (29) . Nucleohistones containing polynucleosomes (Sigma Chemical Co.), heparan sulphate (Sigma Chemical Co.), purified histones H2A, H2B, H3, and H4 (Boehringer Mannheim Co., Indianapolis, IN), small nuclear ribonucleoprotein (snRNP) extract (Chemicon International, Inc., Temecula, CA), and the heat shock proteins HSC 70 and HSP 90 (StressGen Biotechnologies Corp., Victoria, British Columbia, Canada)were also used as antigens in T cell proliferation assays.
T cell proliferation assays. The Th cell lines were maintained by addition of irradiated (3,000 rad) autologous EBV-BCL once a week and rIL-2 (20 U/ml) twice a week. These lines were rested 7-10 d before proliferation assay. 2 x 104 Th line cells were cocultured in triplicate with 4 x 104 irradiated (3,000 rad) antigen-presenting cells (APC) that were either subclones of autologous EBV-BCLs from lupus patients or normal, HLA-matched EBV-BCL, Boleth (a gift from Dr. by each Th line, except JD22 whose TCR /3 chain sequence could not be determined. This observation is consistent with these Th lines being clonal, since they were derived by limiting dilution cultures. Th lines JC2 and JD22 expressed two in-frame TCR a chain mRNA, probably due to the frequent lack of allelic exclusion of TCR a at the message level (30 (Table II) . These Th lines were again DR-restricted and their level of response to the autoantigen was similar to their anti-CD3 response. One of the Th line DD-2, derived from lupus patient DS-2, also responded to histone H-4, but not to the other histone components of the nucleosome (Fig. 6) , whereas Th line MD3 1 derived from patient MCM could respond when presented with the whole nucleosome particle (Table II) , but not when its component histones were fed to the APC (data not shown). Again the mean SI±SD of these Th lines to the other autoantigens in the panel that are not shown in Table II were as follows: DD-2, 1.01±0.1, and MD31, 0.95±0.1.
Finally, 1 of the 10 autoantibody-inducing Th lines, SC31 that was derived from lupus patient SE-2 (Fig. 4, but (14, 15) . Indeed, the target antigens for the autoantibodies of SLE have not only cationic residues but some have long runs of anionic or mixed charge residues (34) . These target autoantigens of lupus B cells may also contain the epitopes for these pathogenic autoantibody-inducing Th clones, since an interaction between reciprocally charged residues in the TCR-CDR3 loop and their corresponding antigenic peptide has been found in several antigenic systems (14, 15, 29, (36) (37) (38) . Besides the charged amino acids highlighted in Figs. 1-5, these autoimmune TCR-CDR3 loops also contain tyrosine, tryptophan, and phenylalanine, whose electron-rich aromatic rings could interact with positively charged residues in the autoantigen(s) (37) . Conversely, glutamine and asparagine which are also present in those CDR3 loops could interact with negatively charged residues in the autoantigen (37) . Of course, other T cells in the lupus patients that are incapable of inducing anti-DNA autoantibodies could also possess charged residues in their TCR since those T cells could be specific for charged peptides derived from exogenous antigens (37, 38) . The charged motif in the CDR3 of the TCRs simply offers a clue regarding the nature of the autoantigens that might prime these autoimmune Th cells of lupus.
The heterogeneity in their junctional sequences indicate that these TCRs are specific for diverse autoantigenic epitopes, however, different TCRs can also recognize a single peptide-MHC complex configuration in different ways (37) (38) (39) . Indeed, in * The proliferative response patterns were reproduced 5-10 times with each Th cell line. SI in response to the nucleoprotein antigen that specifically stimulated a particular Th line were always > 3 SD over the background responses to the nonstimulating antigens. Optimal results are shown, where background stimulation of the Th cells with APC alone presenting nuclear antigens of endogenous origin was low. Significant proliferation and SI in response to the added antigen(s) are shown in bold. All antigens were used at a concentration of 10 pg/ml to pulse the APC. + HLA restriction was determined by blocking of antigen-specific proliferation of the Th clones using a panel of anti-class II mAbs. The anti-DR mAb inhibited proliferation of the Th clones to their respective antigens by 75-95% whereas the anti-DP and anti-DQ mAbs inhibited by only 5-15% (see Fig. 6 ). § Since nuclear antigens from dying cells in the cultures could be presented by the APC even without the addition of such antigens, the background stimulation (T±APC alone) was kept low by loading the APC that are shown in this column only with a control irrelevant antigen like tetanus toxoid (Sigma Chemical Co., 10 pg/ml) to compete with spontaneous autoantigen-processing by the APC. Furthermore, in the case of each Th clone, the nuclear antigens that did not stimulate significantly might have also acted as such competitors.
the murine models of lupus nephritis we find the same heterogeneity in the TCR sequences of pathogenic Th clones that are specific for nucleosomes (14, 15, 29) . In addition to CDR3, other regions of the TCR molecule, particularly CDR1 and CDR2 may also contact the antigenic determinants (40, 41) . Indeed, charged residues were also prominent in these other antigen-binding regions of the lupus TCRs that were found here to be specific for HMG and histone proteins (Fig. 7) . Although the TCR gene usage was heterogeneous in this spontaneous and systemic autoimmune disease, there were some notable recurrences besides the charged motifs. In four of the five patients, the frequency of Va8 gene usage was markedly increased among their pathogenic autoantibody-inducing Th lines ranging from 36 to 100%, in contrast to normal peripheral blood T cells where its expression is only 9% (31, 32) . The frequency of Va8 gene usage was not increased in the total T cell population of lupus patients but only in these select autoimmune Th cells from four out of the five patients. Interestingly, human T cell lines selected for reactivity against another charged autoantigen, myelin basic protein, also use Va8 genes predominantly (42) . Secondly, although not a major feature, several sets of independently derived Th clones from each lupus patient here had identical TCR a or TCR ,6 or both TCRs, such as: Th clones, SC24/SC30, SC33/SC34, SC31/SC32, SC24/ SC31, and SC2/SC3 from patient SE-2 (Fig. 4) ; MD30/MD28 from patient MCM (Fig. 2) ; and JC2/JC3 from patient JCA (Fig. 1) . This feature could again be due to selection of these Th cells by certain autoantigens comparable with other welldefined antigenic systems (37, 38) .
To understand the mechanism of the pathogenic anti-DNA autoantibody response in lupus, it is crucial to determine which autoantigens these autoantibody-inducing Th cells see. Based on the finding of charged residues in their TCRs, we tested the response of the anti-DNA autoantibody-inducing Th lines with certain candidate autoantigens that have charged residues (34) . These autoantigens are recurrently found to be the targets of autoantibodies in lupus and are associated with anti-DNA autoantibody production. We also took into account that these Th lines of lupus preferentially help the select population of B cells that produce potentially pathogenic anti-DNA autoantibodies (1, 11) . Hence, those autoimmune B cells probably in turn pres- (14, (43) (44) (45) (46) . Therefore, we selected those charged autoantigens for testing that could be efficiently picked up by such anti-DNA B cells for processing, such as different nucleoproteins that complex with DNA (HMG, histones), or HSPs that interact with DNA-binding proteins/transcription factors, or ribonucleoproteins and heparan sulfate proteoglycans that are cross-reactive antigens for anti-DNA autoantibodies (29, (47) (48) (49) .
Among 10 anti-DNA autoantibody-inducing Th clones that could be revived for these antigenic specificity studies, 4 responded to the nonhistone chromosomal protein HMG. The HMG proteins are highly charged with runs of negative and positive residues; they associate with DNA in transcriptionally active chromatin (50) . Like anti-dsDNA antibodies, autoantibodies to HMG are frequently found in sera of lupus patients with active disease (27) . But this study does not involve anti-HMG or antihistone antibodies (27, 51) . The remarkable result here is that HMG-reactive T cells help the production of potentially pathogenic anti-DNA autoantibodies in lupus. Anti-HMG antibodies could be an epiphenomena in the pathogenesis of lupus nephritis, since the HMG-specific Th cells would help in the production of both the anti-HMG and the pathogenic variety of anti-DNA autoantibodies. The anti-DNA B cells, which these Th cells specifically help, probably take up DNA-bound HMG and present to these Th cells. Thus the Th cell and B cell epitopes are on different molecules within the same chromatin particle allowing for cognate interaction between the two types of cells (29, 52, 53) . Interestingly, three of the four Th clones responded to HMG only when it was presented as a complex with DNA. Possibly, the peptide epitopes in HMG that are critical for the Th cells were protected by DNA during processing or these Th clones could recognize processed nucleotides (from the DNA) complexed with peptides (from the HMG), like arsenate-or fluorescein-specific T cells that recognize haptens or haptenated peptides (41, 54). Indeed, nucleotidespecific y/6 T cells have been recently described (55). Other Th cells in the panel responded to nucleosomal antigens which are highly charged histones complexed with DNA. One of the Th clones, DD2, actually responded to the arginine-rich histone H4 which is part of the mononucleosome core, whereas the other, MD3 1, responded only when the whole particle was presented and not to its histone components. The latter feature is also observed in case of pathogenic anti-DNA autoantibodyinducing Th cells that respond to nucleosomes in murine SLE (29) . Either nucleosomes as a whole are taken up more efficiently by anti-DNA antibody receptors on the pathogenic B cells (29, 56) or by special nucleosome receptors found on all types of APC (57) . Nucleosome-specific T cells play a major role in the development of lupus nephritis in murine models (29) and consequently production of autoantibodies to nucleosomes is associated with lupus nephritis (29, 58, 59) . It is not clear how autoimmunization against nucleosomes occurs in lupus. These autoantigens are released normally as a product of apoptosis (60, 61) . But large amounts of nucleosomes are released in patients undergoing chronic hemodialysis without the development of lupus (62) . Perhaps abnormal autoantigen processing and presentation could lead to the generation of nucleosome-specific T cells in lupus. Clearly, the pathogenic anti-DNA B cells could perform as abnormal APC (14, 29, 46) . Interestingly, one of the autoantibody-inducing Th lines in the panel, SC3 1, responded consistently to pure dsDNA with a mean SI that was 29 SD above its SI response to the other autoantigens. However, SC3 1 responded poorly to nucleosomes suggesting that this Th line may be specific for nucleotides like some other T cells (55). Although the purified dsDNA preparation (Sigma Chemical Co. catalogue no. D-4764, ultrapure DNA) was devoid of proteins, it could complex with some proteins in the culture and then be presented by the APC. These possibilities will be tested in another study.
Deliberate immunization of mice with various DNA-binding proteins of exogenous or endogenous origin along with CFA leads to the production of anti-DNA autoantibodies, particularly in lupus-prone genetic backgrounds (63) (64) (65) . Even methylated BSA carrier-specific T cells could help in the production of anti-DNA autoantibodies when B/W lupus mice were immunized with methylated BSA-DNA complex (65) . However, herein we have determined which of the naturally occurring and abundant autoantigens could trigger the spontaneously arising Th cells of lupus that preferentially induce potentially pathogenic anti-DNA autoantibodies. Our studies indicate that there is an underlying connection between the different autoantibodyproducing B cells of lupus (35, 66) as the diverse autoimmune B cells could share help from the same Th cells that are specific for endogenous chromosomal proteins that bind DNA. Thus a Th cell specific for HMG in chromatin could help different B cells producing either anti-HMG, or anti-DNA, or antinucleosome, or antihistone autoantibodies, because B cells specific for any of these autoantigenic components of chromatin could efficiently take up and process the entire chromatin particle and present the relevant HMG epitope from it to the Th cell. The same situation would apply to the nucleosome-specific Th cells of lupus (29) . This interaction between the autoimmune T and B cells of human lupus is cognate, being HLA-DR restricted in the panel of Th cells we tested. A similar cognate interaction occurs in murine SLE and also in case of other autoantigenreactive T cells in human lupus (6, 29, 43, (67) (68) (69) (70) (71) . Defining the autoantigenic epitopes for these Th cells that drive the potentially pathogenic autoantibody-producing B cells would lead to an understanding of the etiologic mechanism of human lupus nephritis and specific intervention in the disease.
